Table of contents
Punishing Pain or Saving Lives
The real choice in drug policy reform.
Executive Summary
At this point in the series, the debate is no longer theoretical.
We have already walked through:
• what the current system does
• what alternative models look like
• what real-world case studies show
• what happens if we do nothing
• why reform is politically viable
• why regulation is administratively possible
• why public buy-in can be built
• and why the ethical case for change is stronger than the case for denial
So now the argument simplifies.
This is not about whether drugs are good or bad.
This is about whether policy should continue punishing pain or saving lives.
That is the real choice.
A public health drug policy does not pretend drug use disappears. It tries to reduce death, stabilize people, and create pathways into addiction recovery. A punishment-first system does something else. It treats visible suffering as a problem to manage rather than a problem to solve.
The result is predictable.
Even after improvement, the United States still lost 79,384 people to overdose in 2024.[1] Millions still cannot access treatment. Emergency systems remain overloaded. Families keep absorbing the damage. Communities keep seeing the same cycle play out.
That is not a neutral outcome.
That is a choice.
The Policy Question We Keep Avoiding
Most people think the drug policy reform debate is about drug legalization versus prohibition.
It is not.
The real policy question is this:
When we know people are going to struggle with addiction, what do we do about it?
Do we:
• respond after collapse
• respond after arrest
• respond after overdose
• respond after everything has already gone wrong
Or do we:
• reduce risk before collapse
• intervene earlier
• provide treatment on demand
• build systems that actually stabilize people
That is where punishing pain or saving lives stops being rhetorical.
It becomes operational.
Because the current system is not failing by accident. It is producing exactly what it is designed to produce: late intervention, fragmented care, and heavy reliance on punishment instead of overdose prevention.
1. Punishing Pain: What the Status Quo Actually Does
The phrase “punishing pain” sounds dramatic.
It is not.
It is a description.
When someone is struggling with addiction, the system often does the following:
• delays treatment access
• creates bureaucratic barriers
• routes people through courts instead of care
• attaches long-term consequences to moments of instability
• relies on emergency response instead of prevention
• tolerates a contaminated supply while focusing on enforcement
This is not a caricature. It is the pattern we have already documented across earlier parts.
Part 23 showed what happens when this continues: more overdose, more unstable supply, more black market power, more pressure on emergency systems, and more long-term damage carried by individuals and families.
Part 18 showed how stigma reduction is still incomplete, which makes it harder for people to seek help and easier for systems to deny it.[2]
Part 13 showed how addiction, homelessness, and instability intersect in ways that punishment alone cannot fix.
So when people defend the current system, they are not defending a neutral baseline.
They are defending a system that responds to suffering after it escalates instead of reducing it earlier.
That is what punishing pain looks like.
2. Saving Lives: What a Public Health Drug Policy Actually Does
A public health drug policy starts from a different premise.
It accepts that addiction is:
• a medical condition
• a behavioral condition
• a social condition
• a mental health condition
• a risk environment problem
• and a system design problem
That means the response has to be multi-layered.
A serious public health drug policy includes:
• overdose prevention as a primary goal
• harm reduction tools that reduce immediate risk
• treatment on demand so people can access care when ready
• medication for opioid use disorder as standard practice[3]
• integration with mental health services
• housing and stability supports where needed
• targeted public safety enforcement for real harm
This is not hypothetical.
CDC explicitly frames overdose prevention as a system that includes harm reduction, linkage to care, public safety partnerships, and data-driven intervention.[5]
That is the model.
It does not eliminate risk.
It reduces preventable harm.
And that is the key distinction.
3. The False Fear: Saving Lives Means Losing Accountability
One of the biggest misunderstandings in this debate is the idea that shifting toward saving lives means abandoning rules.
It does not.
A serious model still includes:
• diversion control
• enforcement against trafficking
• enforcement against violence
• enforcement against sales to minors
• enforcement against fraud and contamination
• enforcement against impaired driving
That is not weakened public safety.
That is improved targeting.
Part 10 already made this point clearly.
The goal is not less accountability.
The goal is better accountability.
Instead of punishing people for possession while ignoring systemic failures, a better model holds systems accountable for outcomes:
• are overdoses going down?
• are people entering treatment?
• are repeat crises declining?
• are neighborhoods becoming more stable?
That is a more honest form of accountability.
4. Risk-Based Drug Regulation: The Bridge Between Compassion and Control
This is where risk-based drug regulation becomes critical.
Because the real fear people have is not abstract.
It is this:
“What if we loosen the wrong things and make the problem worse?”
That is a fair concern.
And it is exactly why one-size-fits-all policy fails.
Risk-based drug regulation answers that concern by separating:
• low-risk substances
• moderate-risk substances
• high-risk substances
and assigning different rules to each.
That means:
• tighter structure where risk is highest
• more flexibility where risk is lower
• stronger monitoring where instability is greatest
• clearer pathways into care at every level
Part 9 laid this out in detail.
And Part 14 showed how the highest-risk lane can be handled through a regulated pharmacy model rather than open access.
This is not about removing control.
It is about applying the right level of control to the right level of risk.
That is how you move from punishing pain or saving lives into something more precise: managing risk while reducing harm.
5. Treatment on Demand Is the Line Between Intent and Reality
You can talk about compassion all day.
If people cannot access care when they need it, it does not matter.
That is why treatment on demand is the dividing line.
A system without treatment on demand:
• delays care
• loses people during critical windows
• increases overdose risk
• increases relapse cycles
• increases emergency utilization
A system with treatment on demand:
• captures motivation when it appears
• reduces time between crisis and care
• increases treatment engagement
• reduces repeat overdoses
• stabilizes individuals faster
This is not theory.
This is basic timing.
SAMHSA describes low-barrier models of care as approaches designed to reduce obstacles to addiction recovery and engagement.[4]
Addiction does not operate on a schedule that fits bureaucratic timelines.
So if policy cannot respond when people are ready, it is not a serious policy.
Part 16 emphasized this operational requirement.
And Part 20 reinforced the urgency.
If we are serious about saving lives, then treatment on demand is not optional.
It is foundational.
6. The Emotional Reality: This Is Not Abstract
At some point, policy discussions have to reconnect with reality.
This is not about “users.”
This is about:
• people in your family
• people in your community
• people you went to school with
• people you work with
• people you know
The system does not operate on abstractions.
It operates on human beings.
That is why punishing pain or saving lives matters.
Because the current model often treats addiction as something to distance from rather than something to address.
And that distance makes it easier to tolerate failure.
It makes it easier to accept:
• delayed care
• fragmented systems
• repeated overdoses
• preventable deaths
A public health drug policy collapses that distance.
It forces the system to respond to people as patients, not problems.
That is the ethical shift.
The Bottom Line
At this stage, the debate is not about whether change is possible.
It is about whether we are willing to acknowledge the choice we are already making.
We are already choosing:
• how resources are used
• how systems respond
• what outcomes we tolerate
• what trade-offs we accept
So the real question is not:
“Should we change drug policy?”
The real question is:
Do we continue punishing pain or start saving lives?
A system built on:
• public health drug policy
• overdose prevention
• treatment on demand
• risk-based drug regulation
• accountability
• public safety
is not radical.
It is more aligned with reality.
And at this point, reality is the only thing that matters.
Frequently Asked Questions
What does “punishing pain or saving lives” actually mean?
It means deciding whether drug policy reform should focus on punishment after harm occurs or reducing harm before it escalates.
Does saving lives mean ignoring personal responsibility?
No. A serious system still includes accountability, public safety, and diversion control. It just applies them more effectively.
Why is public health drug policy emphasized so much?
Because it addresses the full system: prevention, treatment, harm reduction, and stabilization — not just enforcement.
What role does risk-based drug regulation play?
Risk-based drug regulation allows different substances and situations to be handled differently, improving both safety and effectiveness.
Why is treatment on demand so important?
Because timing matters. If people cannot access care when they are ready, outcomes worsen.
Is this about full drug legalization?
Not necessarily. It is about building a system that reduces harm, regardless of where different policies fall on the legalization spectrum.
References
[1] Centers for Disease Control and Prevention. U.S. Life Expectancy Hits Record High as Drug Overdose Deaths Decline in 2024. https://www.cdc.gov/nchs/pressroom/releases/20260129.html
[2] Centers for Disease Control and Prevention. Stigma Reduction. https://www.cdc.gov/stop-overdose/stigma-reduction/index.html
[3] National Institute on Drug Abuse. Medications for Opioid Use Disorder. https://nida.nih.gov/research-topics/medications-opioid-use-disorder
[4] Substance Abuse and Mental Health Services Administration. Low Barrier Models of Care. https://library.samhsa.gov/product/advisory-low-barrier-models-care-substance-use-disorders/pep23-02-00-005
[5] Centers for Disease Control and Prevention. Overdose Data to Action. https://www.cdc.gov/overdose-prevention/php/od2a/prevention.html
If you want to follow the full series as it publishes, visit the full Drug Legalization Series. If you prefer audio conversations on recovery, reentry, and purpose, check the podcast page. For program directors building reentry and transition programming, see ReturnPath reentry curriculum. For the personal story behind this work, read A Vision of Hope. To invite Andrew for a keynote or panel, see speaking.